Ligand-mediated nanomedicines against breast cancer: a review
Author:
Affiliation:
1. Department of Basic Pathology, Federal University of Paraná, Curitiba, Paraná, Brazil
2. School of Medicine, Pontifical Catholic University of Paraná, Curitiba, Paraná, Brazil
Abstract
Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Publisher
Future Medicine Ltd
Subject
Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering
Link
https://www.futuremedicine.com/doi/pdf/10.2217/nnm-2021-0473
Reference150 articles.
1. Nanocarriers as an emerging platform for cancer therapy
2. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites
3. Perspectives on the past, present, and future of cancer nanomedicine
4. A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer
5. Cancer‐Targeted Nanomedicine: Overcoming the Barrier of the Protein Corona
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Synergy and Coordination Between Biomimetic Nanoparticles and Biological Cells/Tissues/Organs/Systems: Applications in Nanomedicine and Prospect;Biomedical Materials & Devices;2023-05-08
2. Oxygen therapy alternatives in COVID-19: From classical to nanomedicine;Heliyon;2023-04
3. Towards epigenetic regulation of triple-negative breast cancer via ligand-mediated nanoparticles;Nanomedicine;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3